COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 253: Articles 2521-2530  | Next

Characteristics of SARS-CoV-2 reinfection with Omicron BA.2.75 subvariants in Thai Adults.
Assawakosri, S., Sudhinaraset, N., Chansaenroj, J., Suntronwong, N., Kanokudom, S., Nalinpakorn, N., Tantipraphat, N., Sethabutra, A., Honsawek, S., Poovorawan, Y.
10.1101/2023.11.24.23298841 — Posted: 2023-11-27
SARS-CoV-2 sequencing with cloud-based analysis illustrates expedient co-ordinated surveillance of viral genomic epidemiology across six continents
Amoako, D., Anh, N. T., Brouard, M., Campano Romero, C., Castillo Ramirez, A., Constantinides, B., Crook, D., Cuong, P. M., Diagne, M. M., Diallo, A., Dung, N. T., Dunn, L., Duyet, L. V., Everatt, J., Fletcher, K., Fowler, P., Gail, M., Hospital for Tropical Diseases SARS-CoV-2 testing team, , Hong, N. T. T., Hunt, M., Iqbal, Z., Jeffery, K., Kekana, D., Kesteman, T., Knaggs, J., Lopes Alves, M., Man, D. N. H., Mathers, A., Ngoc, N. M., Oakley, S., Parikh, H., Peto, T., Rojas Herrera, M., Sanderson, N., Sintchenko, V., Swann, J., Tam, N. T., Tan, L. V., Thach, P. N., Top, N. M., Trang, N. T.
10.1101/2023.11.27.23298986 — Posted: 2023-11-27
Effects of Buprenorphine, Methadone and Substance-Use on COVID-19 Morbidity and Mortality
CHRISTIAN, N., ZHOU, X., RADHAKRISHNAN, R.
10.1101/2023.11.24.23298995 — Posted: 2023-11-27
The Antiviral Mechanism of Action of Molnupiravir in Humans with COVID-19
Sheahan, T. P., Stevens, L. J., Narowski, T. M., Krajewski, T. J., Lee, C., Mollan, K. R., Gribble, J., Moreria, F. R., Castillo, I. N., Cuadra, E., Alabanza, P., James Loftis, A., Coombs, R. W., Goecker, E. A., Greninger, A. L., Chappell, J. D., Brown, A. J., Won, J., Lipansky, F., Holman, W., Szewczyk, L. J., Baric, R. S., Painter, W. P., Eron, J. J., Premkumar, L., Denison, M. R., Fischer, W. A.
10.1101/2023.11.21.23298766 — Posted: 2023-11-27
Variant- and Vaccination-Specific Alternative Splicing Profiles in SARS-CoV-2 Infections
Lee, S.-G., Furth, P., Hennighausen, L., Lee, H. K.
10.1101/2023.11.24.568603 — Posted: 2023-11-27
Evolution-guided large language model is a predictor of virus mutation trends
Nie, Z., Liu, X., Chen, J., Wang, Z., Liu, Y., Si, H., Dong, T., Xu, F., Song, G., Wang, Y., Zhou, P., Gao, W., Tian, Y.
10.1101/2023.11.27.568815 — Posted: 2023-11-27
Modulation of human kinase activity through direct interaction with SARS-CoV-2 proteins
Halwachs, B., Moesslacher, C. S., Kohlmayr, J. M., Fasching, S., Masser, S., Choteau, S. A., Zanzoni, A., Stelzl, U.
10.1101/2023.11.27.568816 — Posted: 2023-11-27
Identification of the host reservoir of SARS-CoV-2 and determining when it spilled over into humans
Pamjula, V., Strachan, N. J. C., Perez-Reche, F. J.
10.1101/2023.11.25.568670 — Posted: 2023-11-27
Safe plant Hsp90 adjuvants elicit an effective immune response against SARS-CoV2 derived RBD antigen
Ramos-Duarte, V. A., Orlowski, A., Jaquenod de Giusti, C., Corigliano, M. G., Legarralde, A., Mendoza-Morales, L. F., Atela, A., Sanchez, M. A., Sander, V. A., Angel, S. O., Clemente, M.
10.1101/2023.11.25.568642 — Posted: 2023-11-27
The antiviral potential of the antiandrogen enzalutamide and the viral-androgen interplay in seasonal coronaviruses
Ogunjinmi, O. D., Abdullahi, T., Somji, R.-A., Bevan, C. L., Barclay, W. S., Temperton, N. J., Brooke, G. N., Giotis, E. S.
10.1101/2023.11.25.568685 — Posted: 2023-11-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).